Particularly for EMPD in penoscrotal area, because the common initial sites of EMPD are the scrotum of male in China [16], our data indicated that the 63.33% of EMPD with AR expression in penoscrotal area should be selected for further adjuvant hormonal therapy. The gene discussed is AR; the disease is extramammary Paget disease.